VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NGNE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NGNENeurogene Inc.
$32.56$515M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNGNEPrice History

NGNE logoNeurogene Inc. (NGNE) Stock Price History

Historical prices from 2014 to 2026

$32.56-2.78  (-7.87%)close Jul 6
Returns
1M
+13.8%
3M
+59.1%
YTD
+61.5%
1Y
+67.0%
3Y
+24.9%
5Y
-29.3%
ATH$1,115.00Aug 2015-97.1%
ATL$6.88Apr 2025pre-split
Avg Vol (50D)169K/ day
52-Week Range$15.93 — $37.27
LowCurrent: $32.56High

Loading 10-year price history...

NGNE Historical Performance

1 YearTotal Return
+67.0%
Price: +67.0%
3 YearsTotal Return
+94.7%
CAGR: +24.9%
Price: +94.7%
5 YearsTotal Return
-82.3%
CAGR: -29.3%
Price: -82.3%
YTD
+61.5%

NGNE Annual Returns

Year-by-year price performance · 2014–2026

Best+428.8%2019
Worst-90.3%2022
Up years7/13
2014-37.2%
2015+63.6%
2016+33.9%
2017-27.4%
2018-82.0%
2019+428.8%
2020+19.0%
2021-65.9%
2022-90.3%
2023+91.9%
2024+15.0%
2025-10.0%
2026+16.5%
2014 annual price return
-37.2%
2015 annual price return
+63.6%
2016 annual price return
+33.9%
2017 annual price return
-27.4%
2018 annual price return
-82.0%
2019 annual price return
+428.8%
2020 annual price return
+19.0%
2021 annual price return
-65.9%
2022 annual price return
-90.3%
2023 annual price return
+91.9%
2024 annual price return
+15.0%
2025 annual price return
-10.0%
2026 annual price return
+16.5%
LessMore
Alpha vs S&P 500
1Y+54.0%
3Y+6.7%
5Y-42.7%

Price returns only.

Download Historical Data

3,101 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NGNE Stock Price Trajectory (2014–2026)

As of July 7, 2026, Neurogene Inc. (NGNE) trades at $32.56, representing a +67.0% return over the past year. The stock has delivered a -82.3% total return over five years (-29.3% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $1,115.00 on August 10, 2015. From this peak, NGNE has corrected -97.1%, currently trading 37% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers KRYS (+168.1% 1Y), RCKT (+42.0% 1Y), and PRAX (+571.6% 1Y), NGNE has underperformed the peer group average. Compare NGNE vs KRYS →

NGNE Historical Price Data · from 2014

Rows 1–50 of 3,101
Date Open High Low Close Volume Change %
2026-07-0635.2336.0332.4532.56228K-7.87%
2026-07-0234.1235.7133.4235.34360K+4.31%
2026-07-0131.8934.3531.4333.88677K+7.73%
2026-06-3032.0432.9530.3431.45157K-2.57%
2026-06-2932.7633.4031.6032.28543K+0.78%
2026-06-2630.4932.0630.3432.030+5.33%
2026-06-2530.0732.0029.6630.41156K+1.13%
2026-06-2431.0632.1230.0730.07127K-2.56%
2026-06-2331.8632.6230.8030.86116K-4.31%
2026-06-2232.1132.9731.4532.25173K+2.28%
2026-06-1831.5232.1231.0331.53283K+2.40%
2026-06-1729.7032.2329.0030.79249K+4.91%
2026-06-1630.0030.0028.3429.35149K-1.71%
2026-06-1529.1630.5928.9129.86107K+2.61%
2026-06-1228.8929.7628.2029.10112K+0.34%
2026-06-1128.0529.3327.7529.00124K+3.53%
2026-06-1028.9529.0827.0428.01237K-2.78%
2026-06-0928.9229.8824.9128.81549K+0.73%
2026-06-0826.9928.6026.0928.60129K+7.97%
2026-06-0526.8327.5926.0126.4966K-3.60%
2026-06-0426.4327.9126.1427.4846K+4.81%
2026-06-0326.8927.0225.9226.2282K+0.31%
2026-06-0227.1927.5025.7626.14106K-5.08%
2026-06-0127.7228.8127.0627.54101K-2.82%
2026-05-2927.4028.4627.0128.3496K+3.05%
2026-05-2826.8327.7926.1227.5061K+2.34%
2026-05-2727.1127.7726.7826.8797K-0.85%
2026-05-2627.9728.4826.9427.10120K-2.20%
2026-05-2227.6128.2527.6127.7184K+0.36%
2026-05-2126.4128.1626.1627.61135K+2.45%
2026-05-2027.0528.0826.5026.95156K+0.26%
2026-05-1927.3028.1526.3726.88145K-3.93%
2026-05-1829.2529.5226.8927.98173K-6.17%
2026-05-1529.8431.0429.6329.8287K-4.64%
2026-05-1432.5833.9631.0831.27121K-4.14%
2026-05-1331.5432.9629.7732.62132K+3.42%
2026-05-1230.6631.8830.4531.54103K+2.10%
2026-05-1130.6332.2930.2430.89114K+0.38%
2026-05-0830.4731.8429.6330.77145K-1.56%
2026-05-0732.3032.9729.6231.26152K-3.15%
2026-05-0629.6133.1829.2832.28341K+11.54%
2026-05-0528.0529.1427.4628.94143K+2.55%
2026-05-0427.1328.4426.2228.22118K+5.10%
2026-05-0126.0027.1524.8826.85131K+2.91%
2026-04-3026.5227.0125.3226.09106K-1.47%
2026-04-2926.9227.5426.0026.48245K-3.53%
2026-04-2827.1628.5227.1627.45106K+1.48%
2026-04-2726.8828.5326.8827.05126K+0.07%
2026-04-2426.8127.4126.3727.03273K+0.30%
2026-04-2327.0327.7626.2626.95133K-1.17%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NGNE — Frequently Asked Questions

Quick answers to the most common questions about buying NGNE stock.

How has NGNE stock performed recently?

NGNE returned +67.0% over the past year, beating its 5-year annualized CAGR of -29.3%. The stock trades above its 200-day moving average, confirming the uptrend.

What is NGNE's all-time high price?

Neurogene Inc. reached $1115.00 on 2015-08-10. The 52-week high is $37.27. Current 1-year return of +67.0% places the stock closer to historical peaks.

Where can I download NGNE historical price data?

This page provides NGNE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

444 data points · sampled from 3,101